Abstract
Cell-penetrating peptides (CPPs) are small amino acid sequences with the potential to enter cell membranes. Along with nucleic acids, large proteins, and other chemical compounds, they can deliver several bioactive cargos inside cells. Numerous CPPs have been extracted from natural or synthetic materials since the discovery of the first CPP. In the past few decades, a significant variety of studies have shown the potential of CPPs to cure different diseases. The low toxicity in peptide compared to other drug delivery carriers is a significant benefit of CPP-based therapy, in addition to the high efficacy brought about by swift and effective delivery. A significant tendency for intracellular DNA delivery may also be observed when nanoparticles and the cell penetration peptide are combined. CPPs are frequently used to increase intracellular absorption of nucleic acid, and other therapeutic agents inside the cell. Due to long-term side effects and possible toxicity, its implementation is restricted. The use of cell-permeating peptides is a commonly used technique to increase their intracellular absorption. Additionally, CPPs have lately been sought for application in vivo, following their success in cellular studies. This review will go through the numerous CPPs, the chemical modifications that improve their cellular uptake, the various means for getting them across cell membranes, and the biological activity they acquire after being conjugate with specific chemicals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data is available on request.
References
Adams GP et al (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules 1. Accessed 21 Jan 2021 (Online)
Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2(10):750–763. https://doi.org/10.1038/nrc903
Arrouss I et al (2013) Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy. PLoS ONE 8(4):e60816. https://doi.org/10.1371/journal.pone.0060816
Banks WA (2008) Delivery of peptides to the brain: emphasis on therapeutic development. Biopolymers 90(5):589–594. https://doi.org/10.1002/bip.20980
Bitler B, Schroeder J (2010) Anti-cancer therapies that utilize cell penetrating peptides. Recent Pat Anti-Cancer Drug Discovery 5(2):99–108. https://doi.org/10.2174/157489210790936252
Bolhassani A (2011) Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta Rev Cancer 1816(2):232–246. https://doi.org/10.1016/j.bbcan.2011.07.006
Canton J, Grinstein S (2015) Measuring lysosomal pH by fluorescence microscopy. Methods Cell Biol 126:85–99. https://doi.org/10.1016/bs.mcb.2014.10.021
Casazza AM, Fairchild CR (1996) Paclitaxel (Taxol): mechanisms of resistance. Cancer Treat Res 87:149–171. https://doi.org/10.1007/978-1-4613-1267-3_6
Cell-Penetrating Peptides: Methods and Protocols | Ülo Langel | download (2021) https://b-ok.cc/book/2575108/841916. Accessed 27 Jan 2021
Cheever MA, Higano CS (2011) PROVENGE (sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin Cancer Res 17(11):3520–3526. https://doi.org/10.1158/1078-0432.CCR-10-3126
Chen G, Roy I, Yang C, Prasad PN (2016) Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chem Rev 116(5):2826–2885. https://doi.org/10.1021/acs.chemrev.5b00148
Chiangjong W, Chutipongtanate S, Hongeng S (2020) Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (Review). Int J Oncol 57(3):678. https://doi.org/10.3892/IJO.2020.5099
Chu H-L, Yip B-S, Chen K-H, Yu H-Y, Chih Y-H, Cheng H-T et al (2015) Novel antimicrobial peptides with high anticancer activity and selectivity. PLoS ONE 10(5):e0126390. https://doi.org/10.1371/journal.pone.0126390
CN101926775B (2021) Preparation and application methods of difunctional naonparticle preparation entrapping vincristine sulphate - Google Patents. https://patents.google.com/patent/CN101926775B/en?q=Preparation+and+application+methods+of+difunctional+naonparticle+preparation+entrapping+vincristine+sulphate&oq=Preparation+and+application+methods+of+difunctional+naonparticle+preparation+entrapping+vincristine+sulphate. Accessed 02 Apr 2021
CN102552929A (2021) Method for enhancing targeting selectivity of administration system by modifying cell penetrating peptide - Google Patents.” https://patents.google.com/patent/CN102552929A/en?q=cell+penetrating+peptide+anticancer+nanoparticles&oq=cell+penetrating+peptide+anticancer+nanoparticles&page=11. Accessed 25 Mar 2021
de Figueiredo IR, Freire JM, Flores L, Veiga AS, Castanho MARB (2014) Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies. IUBMB Life 66(3):182–194. https://doi.org/10.1002/iub.1257
Delaroche D et al (2007) Tracking a new cell-penetrating (W/R) nonapeptide, through an enzyme-stable mass spectrometry reporter tag. Anal Chem 79(5):1932–1938. https://doi.org/10.1021/ac061108l
Delehanty JB, Mattoussi H, Medintz IL (2009) Delivering quantum dots into cells: strategies, progress and remaining issues. Anal Bioanal Chem 393(4):1091–1105. https://doi.org/10.1007/s00216-008-2410-4
Demeule M et al (2014) Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties. J Clin Investig 124(3):1199–1213. https://doi.org/10.1172/JCI70647
Derakhshankhah H, Jafari S (2018) Cell penetrating peptides: a concise review with emphasis on biomedical applications. Biomed Pharmacother 108:1090–1096. https://doi.org/10.1016/j.biopha.2018.09.097
Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269(14):10444–10450. https://doi.org/10.1016/s0021-9258(17)34080-2
Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A (1996) Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J Biol Chem 271(30):18188–18193. https://doi.org/10.1074/jbc.271.30.18188
Deshayes S, Morris M, Heitz F, Divita G (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 60(4–5):537–547. https://doi.org/10.1016/j.addr.2007.09.005
Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties. - Abstract - Europe PMC (2021) https://europepmc.org/article/MED/31616141. Accessed 28 Jan 2021
Dokka S, Toledo-Velasquez D, Shi X, Wang L, Rojanasakul Y (1997) Cellular delivery of oligonucleotides by synthetic import peptide carrier. Pharm Res 14(12):1759–1764. https://doi.org/10.1023/A:1012188014919
Dowaidar M, Nasser Abdelhamid H, Hällbrink M, Langel Ü, Zou X (2018) Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles–cell-penetrating peptide. J Biomater Appl 33(3):392–401. https://doi.org/10.1177/0885328218796623
Elliott G, O’Hare P (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88(2):223–233. https://doi.org/10.1016/S0092-8674(00)81843-7
El-Sayed A, Futaki S, Harashima H (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J 11(1):13–22. https://doi.org/10.1208/S12248-008-9071-2
Elson-Schwab L, Garner OB, Schuksz M, Crawford BE, Esko JD, Tor Y (2007) Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem 282(18):13585–13591. https://doi.org/10.1074/jbc.M700463200
Feiner-Gracia N, Dols-Perez A, Royo M, Solans C, Garcia-Celma MJ, Fornaguera C (2018) Cell penetrating peptide grafting of PLGA nanoparticles to enhance cell uptake. Eur Polymer J 108:429–438. https://doi.org/10.1016/j.eurpolymj.2018.09.026
Fuertes M, Castilla J, Alonso C, Pérez J (2012) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10(3):257–266. https://doi.org/10.2174/0929867033368484
Futaki S et al (2001a) Arginine-rich peptides. J Biol Chem 276(8):5836–5840. https://doi.org/10.1074/jbc.M007540200
Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y (2001b) Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276(8):5836–5840. https://doi.org/10.1074/jbc.M007540200
Gessner I, Neundorf I (2020) Nanoparticles modified with cell-penetrating peptides: conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy. Int J Mol Sci 21(7):2536. https://doi.org/10.3390/ijms21072536
Ghaz-Jahanian MA, Abbaspour-Aghdam F, Anarjan N, Berenjian A, Jafarizadeh-Malmiri H (2015) Application of chitosan-based nanocarriers in tumor-targeted drug delivery. Mol Biotechnol 57(3):201–218. https://doi.org/10.1007/s12033-014-9816-3
Gosk S, Moos T, Gottstein C, Bendas G (2008) VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochimica Et Biophysica Acta - Biomembranes 1778(4):854–863. https://doi.org/10.1016/j.bbamem.2007.12.021
Gräslund A, Madani F, Lindberg S, Langel Ü, Futaki S (2011) Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys. https://doi.org/10.1155/2011/414729
Habault J, Poyet JL (2019) Recent advances in cell penetrating peptide-based anticancer therapies. Molecules 24(5):927. https://doi.org/10.3390/molecules24050927
Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6(4):319–327. https://doi.org/10.1016/S1359-0286(02)00117-1
Harada H, Kizaka-Kondoh S, Hiraoka M (2006) Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment. Breast Cancer 13(1):16–26. https://doi.org/10.2325/jbcs.13.16
Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266–276. https://doi.org/10.1093/jnci/93.4.266
Hu Q et al (2012) Intracellular pathways and nuclear localization signal peptide-mediated gene transfection by cationic polymeric nanovectors. Biomaterials 33(4):1135–1145. https://doi.org/10.1016/j.biomaterials.2011.10.023
Huang Y-W, Lee H-J, Tolliver LM, Aronstam RS (2015) Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges. Biomed Res Int 2015:1–16. https://doi.org/10.1155/2015/834079
Huang Y et al (2017) Tumor-penetrating peptide fused to a pro-Apoptotic peptide facilitates effective gastric cancer therapy. Oncol Rep 37(4):2063–2070. https://doi.org/10.3892/or.2017.5440
Jafari S, Dizaj SM, Adibkia K (2015) Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery. BioImpacts 5(2):103–111. https://doi.org/10.15171/bi.2015.10
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. https://doi.org/10.3322/caac.20107
Johansson HJ, Andaloussi SEL, Langel U (2011) Mimicry of protein function with cell-penetrating peptides. In: Methods in molecular biology (Clifton, N.J.), vol 683. Humana Press, pp 233–247. https://doi.org/10.1007/978-1-60761-919-2_17
Jones AT (2007) Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med 11(4):670–684. https://doi.org/10.1111/j.1582-4934.2007.00062.x
Kapoor P, Singh H, Gautam A, Chaudhary K, Kumar R, Raghava GPS (2012) TumorHoPe: a database of tumor homing peptides. PLoS ONE 7(4):e35187. https://doi.org/10.1371/JOURNAL.PONE.0035187
Kersemans V, Cornelissen B (2010) Targeting the tumour: cell penetrating peptides for molecular imaging and radiotherapy. Pharmaceuticals 3(3):600–620. https://doi.org/10.3390/ph3030600
Kharkar PS, Soni G, Rathod V, Shetty S, Gupta MK, Yadav KS (2020) An outlook on procedures of conjugating folate to (co)polymers and drugs for effective cancer targeting. Drug Dev Res 81(7):823–836. https://doi.org/10.1002/ddr.21698
Kirpotin DB et al (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Can Res 66(13):6732–6740. https://doi.org/10.1158/0008-5472.CAN-05-4199
Koren E, Torchilin VP (2012) Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18(7):385–393. https://doi.org/10.1016/J.MOLMED.2012.04.012
Kuhlmann N, Chollet C, Baldus L, Neundorf I, Lammers M (2017) Development of substrate-derived sirtuin inhibitors with potential anticancer activity. ChemMedChem 12(20):1703–1714. https://doi.org/10.1002/cmdc.201700414
Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75(1):1–18. https://doi.org/10.1016/j.colsurfb.2009.09.001
Kurrikoff K, Aphkhazava D, Langel Ü (2019) The future of peptides in cancer treatment. Curr Opin Pharmacol 47:27–32. https://doi.org/10.1016/j.coph.2019.01.008
Layek B, Singh J (2013) Cell penetrating peptide conjugated polymeric micelles as a high performance versatile nonviral gene carrier. Biomacromol 14(11):4071–4081. https://doi.org/10.1021/bm401204n
Lee MT, Hung WC, Chen FY, Huang HW (2005) Many-body effect of antimicrobial peptides: on the correlation between lipid’s spontaneous curvature and pore formation. Biophys J 89(6):4006–4016. https://doi.org/10.1529/biophysj.105.068080
Lei Y, Tang H, Yao L, Yu R, Feng M, Zou B (2008) Applications of mesenchymal stem cells labeled with tat peptide conjugated quantum dots to cell tracking in mouse body. Bioconjug Chem 19(2):421–427. https://doi.org/10.1021/bc0700685
Letoha T et al (2010) Cell-penetrating peptide exploited syndecans. Biochimica Et Biophysica Acta - Biomembranes 1798(12):2258–2265. https://doi.org/10.1016/j.bbamem.2010.01.022
Li G et al (2010) Permeability of endothelial and astrocyte cocultures: In vitro Blood-brain barrier models for drug delivery studies. Ann Biomed Eng 38(8):2499–2511. https://doi.org/10.1007/s10439-010-0023-5
Lindgren ME, Hällbrink MM, Elmquist AM, Langel Ü (2004) Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem J 377(1):69–76. https://doi.org/10.1042/BJ20030760
Liu BR, Liou J-S, Huang Y-W, Aronstam RS, Lee H-J (2013) Intracellular delivery of nanoparticles and DNAs by IR9 cell-penetrating peptides. PLoS ONE 8(5):64205. https://doi.org/10.1371/journal.pone.0064205
Macchi S, Signore G, Boccardi C, di Rienzo C, Beltram F, Cardarelli F (2015) Spontaneous membrane-translocating peptides: influence of peptide self-aggregation and cargo polarity. Sci Rep 5(1):16914. https://doi.org/10.1038/srep16914
Magzoub M, Gräslund A (2004) Cell-penetrating peptides: small from inception to application. Q Rev Biophys 37(2):147–195. https://doi.org/10.1017/S0033583505004014
Mai JC, Shen H, Watkins SC, Cheng T, Robbins PD (2002) Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J Biol Chem 277(33):30208–30218. https://doi.org/10.1074/jbc.M204202200
Marty C, Meylan C, Schott H, Ballmer-Hofer K, Schwendener RA (2004) Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes. Cell Mol Life Sci 61(14):1785–1794. https://doi.org/10.1007/s00018-004-4166-0
Matsuzaki K, Yoneyama S, Murase O, Miyajima K (1996) Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry 35(25):8450–8456. https://doi.org/10.1021/bi960342a
Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8(8):603–612. https://doi.org/10.1038/nrm2216
Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits (2010) Accessed 15 Mar 2021 (Online)
Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discovery Today 17(15–16):850–860. https://doi.org/10.1016/j.drudis.2012.03.002
Moreno VM, Baeza A, Vallet-Regí M (2021) Evaluation of the penetration process of fluorescent collagenase nanocapsules in a 3D collagen gel. Acta Biomater 121:263–274. https://doi.org/10.1016/J.ACTBIO.2020.12.022
Morris MC, Deshayes S, Heitz F, Divita G (2008) Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell 100(4):201–217. https://doi.org/10.1042/bc20070116
Nakayama F et al (2011) Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: Involvement of internalization in the in vivo role of exogenous FGF12. J Biol Chem 286(29):25823–25834. https://doi.org/10.1074/jbc.M110.198267
Neundorf I et al (2009) Fusion of a short HA2-derived peptide sequence to cell-penetrating peptides improves cytosolic uptake, but enhances cytotoxic activity. Pharmaceuticals 2(2):49–65. https://doi.org/10.3390/ph2020049
Ord JM, Wakeland JR, Crie JS, Wildenthal K (1983) Mechanisms of degradation of myofibrillar and nonmyofibrillar protein in heart. Adv Myocardiol 4:195–199. https://doi.org/10.1007/978-1-4757-4441-5_17
Otvos L (2008) Peptide-based drug design: here and now. Methods Mol Biol 494:1–8. https://doi.org/10.1007/978-1-59745-419-3_1
Ozcelikkale A, Moon H, Linnes M, Han B (2017) In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles. Wiley Interdisciplinary Rev Nanomed Nanobiotechnol 9(5):e1460. https://doi.org/10.1002/wnan.1460
Park H, Tsutsumi H, Mihara H (2013) Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles. Biomaterials 34(20):4872–4879. https://doi.org/10.1016/j.biomaterials.2013.03.049
(PDF) Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides | Suzan Hammond and Graham McClorey - Academia.edu (2021) https://www.academia.edu/14399089/Peptide_Nanoparticle_Delivery_of_Charge_Neutral_Splice_Switching_Morpholino_Oligonucleotides. Accessed 24 Mar 2021
Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79. https://doi.org/10.1016/j.ejpb.2015.03.018
Perillo E, Hervé-Aubert K, Allard-Vannier E, Falanga A, Galdiero S, Chourpa I (2017) Synthesis and in vitro evaluation of fluorescent and magnetic nanoparticles functionalized with a cell penetrating peptide for cancer theranosis. J Colloid Interface Sci 499:209–217. https://doi.org/10.1016/j.jcis.2017.03.106
Peyressatre M, Prével C, Pellerano M, Morris MC (2015) Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors. Cancers 7(1):179–237. https://doi.org/10.3390/CANCERS7010179
Prabhakar U et al (2013) Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Can Res 73(8):2412–2417. https://doi.org/10.1158/0008-5472.CAN-12-4561
Qin J, Zhu Y, Zheng D, Zhao Q (2021) pH-sensitive polymeric nanocarriers for antitumor biotherapeutic molecules targeting delivery. Bio-Design Manuf. https://doi.org/10.1007/s42242-020-00105-4
Ragin AD, Morgan RA, Chmielewski J (2002) Cellular import mediated by nuclear localization signal peptide sequences. Chem Biol 9(8):943–948. https://doi.org/10.1016/S1074-5521(02)00189-8
Ramsey JD, Flynn NH (2015) Cell-penetrating peptides transport therapeutics into cells. Pharmacol Ther 154:78–86. https://doi.org/10.1016/j.pharmthera.2015.07.003
Raucher D, Ryu JS (2015) Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol Med 21(9):560–570. https://doi.org/10.1016/j.molmed.2015.06.005
Regberg J, Srimanee A, Langel Ü (2012) Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. Pharmaceuticals 5(9):991–1007. https://doi.org/10.3390/PH5090991
Reissmann S (2014) Cell penetration: scope and limitations by the application of cell-penetrating peptides. J Pept Sci 20(10):760–784. https://doi.org/10.1002/psc.2672
Richard JP et al (2003) Cell-penetrating peptides. J Biol Chem 278(1):585–590. https://doi.org/10.1074/jbc.M209548200
Ruoslahti E (2017) Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev 110–111:3–12. https://doi.org/10.1016/j.addr.2016.03.008
Saif JMS et al (2014) Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. Eur J Immunol 44(4):994–1004. https://doi.org/10.1002/EJI.201343863
Sandgren S, Cheng F, Belting M (2002) Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide: role for cell-surface proteoglycans. J Biol Chem 277(41):38877–38883. https://doi.org/10.1074/jbc.M205395200
Shi NQ, Gao W, Xiang B, Qi XR (2012) Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage. Int J Nanomed 7:1613. https://doi.org/10.2147/IJN.S30104
Sieczkarski SB, Whittaker GR (2002) Dissecting virus entry via endocytosis. J Gen Virol 83(7):1535–1545. https://doi.org/10.1099/0022-1317-83-7-1535
Silva S, Almeida AJ, Vale N (2019) Combination of cell-penetrating peptides with nanoparticles for therapeutic application: a review. Biomolecules 9(1):22. https://doi.org/10.3390/biom9010022
Singh S et al (2015) SATPdb: a database of structurally annotated therapeutic peptides. Nucleic Acids Res 44(D1):D1119–D1126. https://doi.org/10.1093/nar/gkv1114
Snyder EL, Dowdy SF (2004) Cell penetrating peptides in drug delivery. Pharm Res 21(3):389–393. https://doi.org/10.1023/B:PHAM.0000019289.61978.f5
Squires S et al (2013) Effects of redox state on the efficient uptake of cell permeable peptide in mammalian cells. Open Biochem J 7:54–65. https://doi.org/10.2174/1874091x20130531001
Stalmans S, Bracke N, Wynendaele E, Gevaert B, Peremans K, Burvenich C et al (2015) Cell-penetrating peptides selectively cross the blood-brain barrier in vivo. PLoS ONE 10(10):e0139652. https://doi.org/10.1371/journal.pone.0139652
Stephens DJ, Allan VJ (2003) Light microscopy techniques for live cell imaging. Science 300(5616):82–86. https://doi.org/10.1126/science.1082160
Su R, Hu J, Zou Q, Manavalan B, Wei L (2020) Empirical comparison and analysis of web-based cell-penetrating peptide prediction tools. Brief Bioinform 21(2):408–420. https://doi.org/10.1093/bib/bby124
Sw B et al (2016) Large gliadin peptides detected in the pancreas of NOD and healthy mice following oral administration. J Diabetes Res 2016:2424306–2424306. https://doi.org/10.1155/2016/2424306
Swain S, Sahu P, Beg S, Babu S (2016) Nanoparticles for cancer targeting: current and future directions. Curr Drug Deliv 13(8):1290–1302. https://doi.org/10.2174/1567201813666160713121122
Tabujew I, Lelle M, Peneva K (2015) Cell-penetrating peptides for nanomedicine-how to choose the right peptide. BioNanoMaterials 16(1):59–72. https://doi.org/10.1515/bnm-2015-0001
Tang Y, Hu J, Elmenoufy AH, Yang X (2015) Highly efficient FRET system capable of deep photodynamic therapy established on X-ray excited mesoporous LaF3: Tb scintillating nanoparticles. ACS Appl Mater Interfaces 7(22):12261–12269. https://doi.org/10.1021/ACSAMI.5B03067
Tat Protein from Human Immunodeficiency Virus Forms a Metal-Linked Dimer on JSTOR (2021) https://www.jstor.org/stable/1701694?seq=1. Accessed 24 Mar 2021
Thanki K, Kushwah V, Jain S (2015) Recent advances in tumor targeting approaches. Springer, Cham, pp 41–112
Tsoi KM, Dai Q, Alman BA, Chan WCW (2013) Are quantum dots toxic? Exploring the discrepancy between cell culture and animal studies. Acc Chem Res 46(3):662–671. https://doi.org/10.1021/ar300040z
Ulapane KR, Kopec BM, Moral MEG, Siahaan TJ (2017) Peptides and drug delivery. Adv Exp Med Biol 1030:167–184. https://doi.org/10.1007/978-3-319-66095-0_8
Ulbrich K, Holá K, Šubr V, Bakandritsos A, Tuček J, Zbořil R (2016) Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev 116(9):5338–5431. https://doi.org/10.1021/acs.chemrev.5b00589
US20190091350A1 (2021) Cancer Treatment Methods Using Thermotherapy And/Or Enhanced Immunotherapy - Google Patents. https://patents.google.com/patent/US20190091350A1/en?oq=US20190091350A1. Accessed 13 Mar 2021
Veloria JR, Chen L, Li L, Breen GAM, Lee J, Goux WJ (2018) Novel cell-penetrating-amyloid peptide conjugates preferentially kill cancer cells. MedChemComm 9(1):121–130. https://doi.org/10.1039/c7md00321h
Vercauteren D et al (2010) The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther 18(3):561–569. https://doi.org/10.1038/mt.2009.281
Vijakumaran U, Nordin F, Hamid ZA, Abdullah M, Jun TG (2020) Development of cell penetrating peptides for effective delivery of recombinant factors into target cells. Protein Pept Lett 27(11):1092–1101. https://doi.org/10.2174/0929866527666200525164135
Vivès E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272(25):16010–16017. https://doi.org/10.1074/jbc.272.25.16010
Vivès E, Schmidt J, Pèlegrin A (2008) Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta Rev Cancer 1786(2):126–138. https://doi.org/10.1016/j.bbcan.2008.03.001
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799. https://doi.org/10.1038/nm1087
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10(3):310–315. https://doi.org/10.1038/nm996
Xie J et al (2020) Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front Pharmacol 11:697. https://doi.org/10.3389/fphar.2020.00697
Xue FL et al (2007) Enhancement of intracellular delivery of CdTe quantum dots (QDs) to living cells by tat conjugation. J Fluoresc 17(2):149–154. https://doi.org/10.1007/s10895-006-0152-2
Ye J et al (2016) CPP-assisted intracellular drug delivery, what is next? Int J Mol Sci 17(11):1892. https://doi.org/10.3390/IJMS17111892
Zhang XX, Eden HS, Chen X (2012) Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release 159(1):2–13. https://doi.org/10.1016/j.jconrel.2011.10.023
Zhang X, Brossas JY, Parizot C, Zini JM, Rebollo A (2018) Identification and characterization of novel enhanced cell penetrating peptides for anti-cancer cargo delivery. Oncotarget 9(5):5944–5957. https://doi.org/10.18632/oncotarget.23179
Funding
The authors have no relevant financial or non-financial interests to disclose.
Author information
Authors and Affiliations
Contributions
SY and PS are the principal investigators of the study. SY and PS prepared the concept and design. Both authors participated in preparing the final draft of the manuscript, revised the manuscript, and critically evaluated the academic contents.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest regarding the publication of this manuscript.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
We affirm that all the authors have seen, prepared, and agreed to the submission of the paper and their inclusion of name(s) as co-author(s). We also declare that there are no conflicts of interest for the same.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yadav, S., Singh, P. Advancement and application of novel cell-penetrating peptide in cancer management. 3 Biotech 13, 234 (2023). https://doi.org/10.1007/s13205-023-03649-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-023-03649-1